Browse studies

Find your next paid study

1 recruiting study matching your filters

Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer: A Biomarker-Driven Pilot Clinical Trial

The goal of this clinical trial is to learn if alisertib in addition to usual care works to treat HR+/HER2+ breast cancer. The main questions it aims to answer…

HR+/HER2+ Breast CancerMetastatic Breast Cancer

Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT07706179